Workflow
Jiangsu Favored Nanotechnology (688371)
icon
Search documents
菲沃泰:2025年前三季度净利润约2898万元
Mei Ri Jing Ji Xin Wen· 2025-10-24 09:33
Group 1 - The core viewpoint of the article highlights the financial performance of Fivotech, with a revenue of approximately 367 million yuan for the first three quarters of 2025, representing a year-on-year increase of 6% [1] - The net profit attributable to shareholders for the same period is about 28.98 million yuan, showing a year-on-year growth of 6.45% [1] - As of the report date, Fivotech's market capitalization stands at 8 billion yuan [2] Group 2 - The article discusses the broader context of the Chinese innovative drug market, noting that overseas licensing has generated 80 billion USD this year [2] - It raises questions about the disparity between the hot secondary market for biomedicine and the cooling fundraising environment in the primary market [2]
菲沃泰(688371) - 中国国际金融股份有限公司关于江苏菲沃泰纳米科技股份有限公司注销募集资金专户及节余募集资金永久补充流动资金的核查意见
2025-10-24 09:33
流动资金的核查意见 中国国际金融股份有限公司(以下简称"中金公司"或"保荐机构")作为 江苏菲沃泰纳米科技股份有限公司(以下简称"菲沃泰"或"公司")的保荐机 构,根据《上市公司募集资金监管规则》《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》等有关法律、行政法规、部门规章及业务规则的 要求,对菲沃泰本次注销募集资金专户及节余募集资金永久补充流动资金事项进 行了认真、审慎核查,具体情况如下: 一、募集资金基本情况 经中国证券监督管理委员会证监许可[2022]1078 号《关于同意江苏菲沃泰纳 米科技股份有限公司首次公开发行股票注册的批复》,同意公司首次公开发行股 票的注册申请,公司向社会公开发行人民币普通股(A 股)股票 83,868,089 股 (每股面值人民币 1 元),每股发行价 18.54 元/股,募集资金总额 1,554,914,370.06 元,扣除不含税的发行费用人民币 118,528,277.06 元,实际募集资金净额为 1,436,386,093.00 元。立信会计师事务所(特殊普通合伙)于 2022 年 7 月 28 日 对本次发行的募集资金到位情况进行了审验,并出具了 ...
菲沃泰(688371) - 北京市中伦律师事务所关于江苏菲沃泰纳米科技股份有限公司注销2024年股票期权激励计划部分股票期权的法律意见书
2025-10-24 09:33
北京市中伦律师事务所 关于江苏菲沃泰纳米科技股份有限公司 注销 2024 年股票期权激励计划部分股票期权的 法律意见书 2025 年 10 月 北京 ・ 上海 ・ 深圳 ・ 广州 ・ 武汉 ・ 成都 ・ 重庆 ・ 青岛 ・ 杭州 ・ 南京 ・ 海口 ・ 东京 ・ 香港 ・ 伦敦 ・ 纽约 ・ 洛杉矶 ・ 旧金山 ・ 阿拉木图 Beijing • Shangha • Shenzhen • Guangzhou • Wuhan • Chengdu • Changzhou • Nangzhou • Nangzhou • Nangzhou • Nangzhou • Nangzhou • Almatyso • London • New York • Los Angeles • 北京市朝阳区金和东路20号 22-31/F, South Tower of CP Center, 20 Jin He East A Beijing 100020, P.R. China 申话/Tel : +86 10 5957 2288 传真/Fax : +86 10 6568 北京市中伦律师事务所 关于江苏菲沃泰纳米科技股份有限公司 注销 202 ...
菲沃泰(688371) - 江苏菲沃泰纳米科技股份有限公司信息披露豁免与暂缓管理制度(2025年10月)
2025-10-24 09:32
江苏菲沃泰纳米科技股份有限公司 信息披露豁免与暂缓管理制度 第一章 总 则 第一条 为规范江苏菲沃泰纳米科技股份有限公司(以下简称"公司")信息 披露暂缓与豁免行为,确保公司依法合规地履行信息披露义务,保护投资者的合 法权益,依据《中华人民共和国证券法》《上市公司信息披露管理办法》《上市 公司信息披露暂缓与豁免管理规定》《上海证券交易所科创板股票上市规则》( 以下简称"《上市规则》")和《上海证券交易所科创板上市公司自律监管指引 第1号——规范运作》等法律、法规、规范性文件的相关规定以及《江苏菲沃泰纳 米科技股份有限公司章程》(以下简称"《公司章程》")以及《江苏菲沃泰纳 米科技股份有限公司信息披露制度》,制定本制度。 第二条 公司按照相关法律、法规、规范性文件、《上市规则》及上海证券交 易所(以下简称"上交所")其他相关业务规则的规定,暂缓、豁免披露临时报 告,在定期报告、临时报告中豁免披露中国证券监督管理委员会(以下简称"中国 证监会")和上交所规定或者要求披露的内容,适用本制度。 第三条 公司应当披露的信息存在《上市规则》及上交所其他相关业务规则中 规定的暂缓、豁免情形的,可以无须向上交所申请,由公司自 ...
菲沃泰(688371) - 关于变更董事会秘书、财务总监的公告
2025-10-24 09:31
证券代码:688371 证券简称:菲沃泰 公告编号:2025-043 江苏菲沃泰纳米科技股份有限公司 关于变更董事会秘书、财务总监的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、提前离任的基本情况 (一)董事会秘书、财务总监离任的基本情况 | 姓名 | 离任职务 | | 离任时间 | 原定任期 到期日 | | | 是否继续 在上市公 | | 是否存在 未履行完 毕的公开 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | 离任原因 | 司及其控 股子公司 任职 | 具体职务(如适 用) | 承诺 | | 宗坚 | 财务总监 | 2025 月 | 年 10 23 日 | 2026 年 月 21 | 12 日 | 工作调整 | 是 | 董事长、总经理 | 是 | | 孙西林 | 董事会秘 书 | 2025 月 | 年 10 23 日 | 2026 年 月 21 | 12 日 | 工作调整 | 是 | 董事、副总经理 ...
菲沃泰(688371) - 关于注销募集资金专户及节余募集资金永久补充流动资金的公告
2025-10-24 09:31
江苏菲沃泰纳米科技股份有限公司 关于注销募集资金专户及节余募集资金永久补 充流动资金的公告 证券代码:688371 证券简称:菲沃泰 公告编号:2025-045 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 江苏菲沃泰纳米科技股份公司(以下简称"公司")于 2025 年 10 月 23 日、 2025 年 10 月 24 日分别召开第二届董事会审计委员会第十二次会议、第二届董 事会第十六次会议,审议通过了《关于注销募集资金专户及节余募集资金永久补 充流动资金的议案》,同意公司将首次公开发行股票募集资金投资项目(以下简 称"募投项目")节余募集资金永久补充流动资金,同时办理注销相关募集资金专 户等相关手续。本次事项在公司董事会审批权限范围内,无需提交股东大会审议。 公司董事会审计委员会发表了同意的意见,保荐机构中国国际金融股份有限公司 (以下简称"保荐机构")对本事项出具了明确无异议的核查意见,现将具体情况 公告如下: 一、 募集资金基本情况 | 发行名称 | 2022 | 年首次公开发行股份 | | | -- ...
菲沃泰(688371) - 第二届董事会第十六次会议决议公告
2025-10-24 09:30
证券代码:688371 证券简称:菲沃泰 公告编号:2025-042 江苏菲沃泰纳米科技股份有限公司 第二届董事会第十六次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 (一)江苏菲沃泰纳米科技股份有限公司(以下简称"公司")第二届董事 会第十六次会议的通知和增加议案的通知已于 2025 年 10 月 19 日和 2025 年 10 月 23 日以电子邮件方式向全体董事及高级管理人员送达,并取得全体董事对本 次会议按期召开的同意和认可。董事会会议通知包括会议的相关材料,同时列明 了会议的召开时间、地点、内容和方式。 (二)本次会议于 2025 年 10 月 24 日上午在公司会议室召开,采取现场会 议结合通讯方式进行表决。本次会议应出席董事九人,实际出席董事九人。会议 由董事长宗坚先生主持,公司高级管理人员列席了本次会议。 (三)本次会议的召集和召开程序符合《中华人民共和国公司法》(以下简 称"《公司法》")《上海证券交易所科创板股票上市规则》(以下简称"《上 市规则》")等相关法律、 ...
菲沃泰(688371) - 2025 Q3 - 季度财报
2025-10-24 09:30
Financial Performance - The company's operating revenue for the third quarter was ¥138,216,124.56, an increase of 4.47% compared to the same period last year[4] - The total profit for the quarter was ¥14,768,874.66, a decrease of 3.22% year-on-year[4] - The net profit attributable to shareholders was ¥12,264,200.37, reflecting a growth of 4.74% compared to the previous year[4] - The net profit attributable to shareholders for the year-to-date was ¥28,977,693.64, an increase of 6.45% compared to the same period last year[4] - Net profit for the first three quarters of 2025 was CNY 28,977,693.64, compared to CNY 27,221,499.80 in 2024, representing a growth of 6.4%[22] Cash Flow - The cash flow generated from operating activities for the year-to-date was ¥40,770,778.60, an increase of 52.45% compared to the previous year[10] - The net cash flow from operating activities for the first three quarters of 2025 was CNY 40,770,778.60, an increase from CNY 26,743,664.77 in 2024[23] - The net increase in cash and cash equivalents for the period was $106,706,280.67, compared to $6,119,373.82 in the previous period, showing significant improvement[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,087,523,605.04, representing a 3.06% increase from the end of the previous year[5] - The total current assets amounted to ¥1,031,377,160.24, up from ¥1,004,727,667.08, indicating an increase of 2.6%[16] - The total liabilities of the company as of the reporting date were CNY 118,279,050.18, a slight decrease from CNY 125,026,722.65 in the previous period[18] - The total equity attributable to shareholders of the parent company was CNY 1,969,244,554.86, compared to CNY 1,900,547,548.83 in the previous year, reflecting an increase of 3.6%[18] Research and Development - Research and development expenses totaled ¥21,802,189.12 for the quarter, accounting for 15.77% of operating revenue, a decrease of 1.57 percentage points year-on-year[5] - Research and development expenses for the first three quarters of 2025 amounted to CNY 66,715,226.72, compared to CNY 63,841,655.47 in 2024, indicating a rise of 4.4%[21] Shareholder Information - The total number of common shareholders at the end of the reporting period is 7,450[12] - Favored Tech Corporation Limited holds 62.16% of the shares, totaling 208,533,334 shares[12] Other Financial Metrics - The weighted average return on net assets was 0.64%, an increase of 0.04 percentage points compared to the previous year[5] - The company achieved a gross profit margin of approximately 53.7% in the first three quarters of 2025, compared to 52.5% in the same period of 2024[21] - Basic earnings per share for the first three quarters of 2025 were CNY 0.09, up from CNY 0.08 in the same period of 2024[22] Non-Recurring Gains and Losses - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥2,687,660.88, down 70.49% year-on-year, primarily due to increased personnel costs related to business transformation[9] - The company reported a total of ¥9,576,539.49 in non-recurring gains for the quarter[8] Investment Activities - Net cash flow from investment activities amounted to $24,783,531.63, compared to $114,702,183.07 in the previous period, indicating a decrease in investment cash flow[24] - Cash outflow from investment activities totaled $374,843,526.71, compared to $1,137,223,461.26 in the previous period, reflecting a reduction in investment spending[24] - Cash inflow from investment activities was $399,627,058.34, compared to $1,251,925,644.33 in the previous period, indicating a decline in cash received from investments[24] Future Accounting Standards - The company plans to implement new accounting standards starting in 2025, which may affect the financial statements[25]
菲沃泰10月10日获融资买入676.66万元,融资余额1.19亿元
Xin Lang Cai Jing· 2025-10-13 01:33
Core Viewpoint - The company Feiwo Tai experienced a decline in stock price and trading volume on October 10, 2023, with significant financing activities indicating a high level of market engagement despite the drop in share price [1] Financing Summary - On October 10, 2023, Feiwo Tai's financing buy-in amounted to 6.77 million yuan, while financing repayment reached 9.90 million yuan, resulting in a net financing outflow of 3.14 million yuan [1] - The total financing and securities balance for Feiwo Tai as of October 10, 2023, was 119 million yuan, representing 1.44% of the circulating market value, which is above the 90th percentile of the past year [1] - The company had no short-selling activities on the same day, with a short-selling balance of 0.00 shares, indicating a lack of bearish sentiment in the market [1] Company Overview - Feiwo Tai, established on August 16, 2016, and listed on August 2, 2022, is located in Wuxi, Jiangsu Province [1] - The company specializes in the research and development of nanomaterials technology suitable for complex application environments, focusing on high-performance, multifunctional nanofilms [1] - The revenue composition of Feiwo Tai includes 93.60% from nanofilm products, 4.25% from other sources, and 2.15% from nanofilm equipment [1] Financial Performance - For the period from January to June 2025, Feiwo Tai reported an operating income of 229 million yuan, reflecting a year-on-year growth of 6.95% [2] - The net profit attributable to the parent company for the same period was 16.71 million yuan, showing a year-on-year increase of 7.74% [2] - As of June 30, 2025, the number of shareholders for Feiwo Tai was 8,151, a decrease of 4.48% from the previous period, while the average circulating shares per person increased by 4.69% to 15,573 shares [2] Institutional Holdings - As of June 30, 2025, Guoshou Anbao Smart Life Stock A (001672) was the fourth largest circulating shareholder of Feiwo Tai, holding 2.81 million shares as a new investor [2]
菲沃泰现6笔大宗交易 合计成交137.50万股
Group 1 - The core point of the news is that Feiwo Tai conducted significant block trades on October 9, with a total trading volume of 1.375 million shares and a total transaction amount of 33.454 million yuan, indicating active institutional participation [2][3] - The average transaction price during these block trades was 24.33 yuan, which represents a discount of 2.01% compared to the closing price of 24.83 yuan on the same day [2][3] - Over the past three months, Feiwo Tai has recorded a total of 8 block trades, amounting to 38.9745 million yuan [2] Group 2 - The stock's latest margin financing balance is 11.9 million yuan, with an increase of 3.8871 million yuan over the past five days, reflecting a growth rate of 3.38% [3] - The stock experienced a decline of 0.80% on the day of the report, with a trading turnover rate of 1.25% and a total trading volume of 105 million yuan, alongside a net outflow of 11.6109 million yuan in main funds [2] - In the last five days, the stock has seen a cumulative decline of 6.65%, with a total net outflow of 30.0133 million yuan [2]